J. Ghosn

Most-cited papers

1. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

   P. Bastard, Lindsey B. Rosen, Qian Zhang, E. Michailidis +95 more

   2020Science2,497 citations Open access

   Semantic Scholar

   Save

2. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review

   Thibault Fiolet, Y. Kherabi, C. Macdonald, J. Ghosn +1 more

   2021Clinical Microbiology and Infection822 citations Open access

   Semantic Scholar

   Save

3. Mpox in people with advanced HIV infection: a global case series.

   O. Mitjà, A. Alemany, M. Marks, Jezer I. Lezama Mora +24 more

   2023The Lancet393 citations Open access

   Semantic Scholar

   Save

4. A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

   L. Grzelak, S. Temmam, C. Planchais, Caroline Demeret +52 more

   2020Science Translational Medicine253 citations Open access

   Semantic Scholar

   Save

5. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

   Pierre-Louis Gilles Arthur Xavier Olivier Matthieu Raphael Phil Tharaux Pialoux Pavot Mariette Hermine Resche-Rigo, P. Tharaux, Gilles Pialoux, Arthur Pavot +496 more

   2021The Lancet Respiratory Medicine243 citations Open access

   Semantic Scholar

   Save

6. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort

   N. Néant, G. Lingas, Q. Le Hingrat, J. Ghosn +30 more

   2021Proceedings of the National Academy of Sciences of the United States of America214 citations Open access

   Semantic Scholar

   Save

7. Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study

   M. Mailhe, Anne-Lise Beaumont, M. Thy, D. le Pluart +18 more

   2022Clinical Microbiology and Infection205 citations Open access

   Semantic Scholar

   Save

8. Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity

   H. Flament, Matthieu Rouland, L. Beaudoin, A. Toubal +31 more

   2021Nature Immunology185 citations Open access

   Semantic Scholar

   Save

9. Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France

   V. Ferré, A. Bachelard, Meryem Zaidi, L. Armand-Lefèvre +3 more

   2022Annals of Internal Medicine140 citations

   Semantic Scholar

   Save

10. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort

    J. Ghosn, L. Piroth, O. Epaulard, P. Le Turnier +3 more

    2021Clinical Microbiology and Infection132 citations Open access

    Semantic Scholar

    Save

11. Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series

    J. Thornhill, Romain Palich, J. Ghosn, S. Walmsley +38 more

    2022The Lancet124 citations Open access

    Semantic Scholar

    Save

12. Omicron SARS-CoV-2 variant: What we know and what we don’t

    V. Ferré, Nathan Peiffer-Smadja, B. Visseaux, D. Descamps +2 more

    2021Anaesthesia Critical Care & Pain Medicine110 citations Open access

    Semantic Scholar

    Save

13. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort

    E. Gentilotti, A. Górska, A. Tami, R. Gusinow +193 more

    2023EClinicalMedicine108 citations Open access

    Semantic Scholar

    Save

14. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.

    J. Molina, J. Ghosn, L. Assoumou, C. Delaugerre +18 more

    2022The Lancet HIV105 citations Open access

    Semantic Scholar

    Save

15. The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients

    M. Perreau, Madeleine Suffiotti, P. Marques-Vidal, A. Wiedemann +12 more

    2021Nature Communications105 citations Open access

    Semantic Scholar

    Save

16. Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19.

    J. Arribas, S. Bhagani, S. Lobo, I. Khaertynova +16 more

    2021NEJM Evidence101 citations

    Semantic Scholar

    Save

17. Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study

    S. Epelboin, J. Labrosse, J. de Mouzon, P. Fauque +9 more

    2021PLoS Medicine76 citations Open access

    Semantic Scholar

    Save

18. Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study.

    T. Bettuzzi, A. Jourdes, O. Robineau, I. Alcaraz +12 more

    2021Lancet. Infectious Diseases (Print)70 citations Open access

    Semantic Scholar

    Save

19. Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity

    Nikaïa Smith, Céline Possémé, V. Bondet, J. Sugrue +19 more

    2022Nature Communications65 citations Open access

    Semantic Scholar

    Save

20. Update of Perinatal HIV-1 Transmission in France: zero transmission for 5482 mothers on continuous ART from conception and with undetectable viral load at delivery.

    J. Sibiude, J. le Chenadec, L. Mandelbrot, Alexandre Hoctin +10 more

    2022Clinical Infectious Diseases60 citations

    Semantic Scholar

    Save

21. Breakthrough Infections after Postexposure Vaccination against Mpox.

    Michael Thy, N. Peiffer-Smadja, M. Mailhe, Laura Kramer +23 more

    2022New England Journal of Medicine58 citations Open access

    Semantic Scholar

    Save

22. Long‐acting injectable cabotegravir for PrEP: A game‐changer in HIV prevention?

    G. Liegeon, J. Ghosn

    2022HIV Medicine57 citations Open access

    Semantic Scholar

    Save

23. Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19

    Matthew G. Johnson, A. Puenpatom, P. Moncada, L. Burgess +12 more

    2022Annals of Internal Medicine55 citations Open access

    Semantic Scholar

    Save

24. Risk and Cost Associated With Drug–Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France

    Ludivine Demessine, L. Peyro-Saint-Paul, E. Gardner, J. Ghosn +1 more

    2019Open Forum Infectious Diseases51 citations Open access

    Semantic Scholar

    Save

25. Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2

    N. Peiffer-Smadja, A. Bridier-Nahmias, V. Ferré, C. Charpentier +9 more

    2021Viruses47 citations Open access

    Semantic Scholar

    Save

26. Inhibition of HECT E3 ligases as potential therapy for COVID-19

    G. Novelli, Jing Liu, M. Biancolella, T. Alonzi +36 more

    2021Cell Death and Disease46 citations Open access

    Semantic Scholar

    Save

27. Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19

    M. Betton, M. Livrozet, D. Planas, A. Fayol +14 more

    2021Clinical Infectious Diseases39 citations Open access

    Semantic Scholar

    Save

28. The value of open-source clinical science in pandemic response: lessons from ISARIC

    Ali Sheryl Ann Nurul Najmee Ryuzo Laurent Lara Subhash Abbas Abdukahil Abdulkadir Abe Abel Absil Acharya , A. Abbas, S. Abdukahil, Nurul Najmee Abdulkadir +496 more

    2021Lancet. Infectious Diseases (Print)34 citations Open access

    Semantic Scholar

    Save

29. Case report study of the first five COVID-19 patients treated with remdesivir in France

    M. Dubert, B. Visseaux, V. Isernia, L. Bouadma +11 more

    2020International Journal of Infectious Diseases34 citations Open access

    Semantic Scholar

    Save

30. Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.

    A. Ursenbach, Vincent Max, M. Maurel, F. Bani-Sadr +297 more

    2020Journal of Antimicrobial Chemotherapy33 citations

    Semantic Scholar

    Save

31. Monkeypox outbreak 2022: an unusual case of peritonsillar abscess in a person previously vaccinated against smallpox.

    B. Davido, E. D’anglejan, Robin Baudoin, Lotfi Dahmane +5 more

    2022Journal of Travel Medicine27 citations

    Semantic Scholar

    Save

32. A Healthcare-Associated Infection With Monkeypox Virus of a Healthcare Worker During the 2022 Outbreak

    D. le Pluart, Mirabelle Ruyer-Thompson, V. Ferré, M. Mailhe +6 more

    2022Open Forum Infectious Diseases25 citations Open access

    Semantic Scholar

    Save

33. IMPACT EVALUATION ON THE WELL-BEING OF SYRIAN REFUGEES

    In Lebanon, Jad Chaaban, H. Ghattas, Nisreen Salti +12 more

    202024 citations

    Semantic Scholar

    Save

34. Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study

    P. Eloy, C. Tardivon, G. Martin-Blondel, M. Isnard +15 more

    2021International Journal of Infectious Diseases20 citations Open access

    Semantic Scholar

    Save

35. How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR study

    C. Puppo, B. Spire, S. Morel, M. Génin +7 more

    2020AIDS Care20 citations

    Semantic Scholar

    Save

36. A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox

    L. L. Luong Nguyen, J. Ghosn, C. Durier, C. Tachot +13 more

    2022Nature Medicine19 citations

    Semantic Scholar

    Save

37. Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group

    O. Hermine, X. Mariette, R. Porcher, F. Djossou +56 more

    2022EClinicalMedicine19 citations Open access

    Semantic Scholar

    Save

38. Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.

    C. Charpentier, A. Storto, C. Soulié, V. Ferré +12 more

    2021Journal of Antimicrobial Chemotherapy18 citations

    Semantic Scholar

    Save

39. Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study

    R. Borie, L. Savale, A. Dossier, J. Ghosn +30 more

    2020PLoS ONE17 citations Open access

    Semantic Scholar

    Save

40. Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening method

    Benoît Heid-Picard, B. Cochand-Priollet, F. Rozenberg, David Giang-Phang +3 more

    2021PLoS ONE16 citations Open access

    Semantic Scholar

    Save

41. Prevalence of STIs, sexual practices and substance use among 2083 sexually active unmarried women in Lebanon

    S. Zaki, Jihane Naous, A. Ghanem, Diana Abou Abbas +3 more

    2021Scientific Reports16 citations Open access

    Semantic Scholar

    Save

42. Perception of PrEP‐related stigma in PrEP users: Results from the ANRS‐PREVENIR cohort

    C. Protière, L. Sagaon-Teyssier, C. Donadille, A. Sow +11 more

    2023HIV Medicine15 citations Open access

    Semantic Scholar

    Save

43. Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults

    Juliette Patrier, Khanh Villageois-Tran, Piotr Szychowiak, S. Ruckly +85 more

    2022Critical Care15 citations Open access

    Semantic Scholar

    Save

44. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

    A. Atkinson, J. Miró, A. Mocroft, P. Reiss +12 more

    2021Journal of the International AIDS Society15 citations Open access

    Semantic Scholar

    Save

45. SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital

    V. Isernia, Z. Julia, S. le Gac, A. Bachelard +8 more

    2020International Journal of Infectious Diseases15 citations Open access

    Semantic Scholar

    Save

46. Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1

    A. Bachelard, A. Sautereau, M. Digumber, V. Isernia +6 more

    2022International Journal of Infectious Diseases14 citations Open access

    Semantic Scholar

    Save

47. Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach

    Mathieu Castry, A. Cousien, V. Supervie, A. Velter +4 more

    2020Gut14 citations

    Semantic Scholar

    Save

48. High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours: results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022

    R. Palich, Andrés Arias-Rodríguez, M. Duracinsky, Jean-Yves Le Talec +15 more

    2024Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin13 citations Open access

    Semantic Scholar

    Save

49. Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study

    M. Legrand, N. Fong, C. Laouénan, J. Ghosn +8 more

    2022BMJ Medicine13 citations Open access

    Semantic Scholar

    Save

50. Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort

    J. Ghosn, D. Bachelet, M. Livrozet, M. Cervantes‐gonzalez +22 more

    2022Clinical Microbiology and Infection13 citations Open access

    Semantic Scholar

    Save